Henlius Finds Global Partner For Ophthalmic Bevacizumab

Strikes Deal With Essex Bio-Technology For Biosimilar Avastin Rival

 
• By David Wallace
  
Eye
Henlius and Essex will collaborate on the biosimilar for ophthalmic indications • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products